Vizgen and Ultivue, two companies at the forefront of developing technologies that allow scientists to map the molecular makeup of cells in exquisite detail, are …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Early menopausal hormone therapy neither benefits nor harms long-term cognition, offering reassurance but no protection against cognitive decline in healthy women.
CG Oncology remains the biggest IPO winner this year, having raised $380m in January. Image credit: Shutterstock / JHVEPhoto. Bicara Therapeutics has raised $362m in
Older patients with classical Hodgkin lymphoma unsuitable for conventional chemotherapy had high rates of durable responses with two brentuximab vedotin (BV; Adcetris) regimens, one that